Home › Myositis › Iowa › Cedar Rapids
Myositis clinical trials in Cedar Rapids, IA
4 studies for Myositis are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Iowa, Iowa City · 25 mi away
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- University of Iowa, Iowa City · 25 mi away
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RecruitingPhase 1
- Research Site, Iowa City · 25 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Iowa, Iowa City · 25 mi away
About Myositis
Myositis means inflammation of the muscles. Two specific types are polymyositis and dermatomyositis. Read about myositis symptoms and management.
More about Myositis on MedlinePlus
Myositis trials in other cities
- Durham, NC10 studies
- Boston, MA6 studies
- New York City, NY6 studies
- Miami, FL5 studies
- Chicago, IL5 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Baltimore, MD4 studies
- Pittsburgh, PA3 studies
- Plantation, FL3 studies
- Phoenix, AZ3 studies
- Jacksonville, FL3 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma16 studies
- Acute Myeloid Leukemia15 studies
- Colorectal Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Prostate Cancer12 studies
- Melanoma11 studies
- Metastatic Cancer9 studies
- Blood Cancers9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.